FDA Approves Second Drug for Alzheimer Disease, Despite Safety Concerns

FRIDAY, Jan. 6, 2023 -- The U.S. Food and Drug Administration on Friday approved a second drug for Alzheimer disease, Leqembi (lecanemab-irmb), despite reports of rare brain bleeds linked to use of the drug in some patients.
Leqembi, made by Eisai...